Department of Pediatrics, Korea University Ansan Hospital, Ansan, Korea.
Department of Pediatrics, Korea University Guro Hospital, Seoul, Korea.
J Korean Med Sci. 2020 Mar 16;35(10):e65. doi: 10.3346/jkms.2020.35.e65.
Neutrophil gelatinase-associated lipocalin (NGAL), a bacteriostatic agent, is known to inhibit erythropoiesis leading to anemia. We aimed to investigate the associations of NGAL, anemia, and renal scarring in children with febrile urinary tract infections (UTIs).
We retrospectively reviewed the medical records of 261 children with febrile UTIs. The relationship between the presence of anemia and plasma NGAL levels was investigated. NGAL performance in comparison with serum C-reactive protein (CRP) at admission and after 72 hours of treatment was also evaluated for the prediction of renal scarring as well as acute pyelonephritis (APN) and vesicoureteral reflux (VUR).
Plasma NGAL levels were elevated in patients with anemia compared with those without anemia. Multiple linear regression analysis showed an inverse relationship between NGAL levels and erythrocyte counts (standard β = -0.397, < 0.001). Increased NGAL, but not CRP, was independently associated with the presence of anemia (odds ratio [OR], 2.37; 95% confidence interval [CI], 1.07-5.27; < 0.05). Receiver operating curve analyses showed good diagnostic profiles of pre- and post-treatment NGAL for identifying APN, VUR, and renal scarring (all < 0.05). For detecting renal scars, the area under the curve of post-treatment NGAL (0.730; 95% CI, 0.591-0.843) was higher than that of post-treatment CRP (0.520; 95% CI, 0.395-0.643; < 0.05). The presence of anemia and elevated NGAL at admission (> 150 ng/mL) were independent risk factors for renal scarring in children with febrile UTIs. With anemia, NGAL levels increased consecutively in children with febrile UTI without renal involvement, with APN without scar, and with APN with renal scarring.
Increased plasma NGAL levels may be associated with the presence of anemia and renal scarring in children with febrile UTIs.
中性粒细胞明胶酶相关脂质运载蛋白(NGAL)是一种抑菌剂,已知其可抑制红细胞生成,导致贫血。本研究旨在探讨中性粒细胞明胶酶相关脂质运载蛋白(NGAL)、贫血和发热性尿路感染(UTI)患儿肾瘢痕之间的关系。
我们回顾性分析了 261 例发热性尿路感染患儿的病历。研究了贫血患儿血浆 NGAL 水平与贫血的关系。还评估了 NGAL 在入院时和治疗 72 小时后与血清 C 反应蛋白(CRP)的表现,以预测肾瘢痕、急性肾盂肾炎(APN)和膀胱输尿管反流(VUR)。
与无贫血的患者相比,贫血患者的血浆 NGAL 水平升高。多元线性回归分析显示 NGAL 水平与红细胞计数呈负相关(标准β=-0.397, < 0.001)。升高的 NGAL,但不是 CRP,与贫血的存在独立相关(比值比[OR],2.37;95%置信区间[CI],1.07-5.27; < 0.05)。受试者工作特征曲线分析显示,治疗前后 NGAL 对识别 APN、VUR 和肾瘢痕具有良好的诊断特征(均 < 0.05)。对于检测肾瘢痕,治疗后 NGAL 的曲线下面积(0.730;95%CI,0.591-0.843)高于治疗后 CRP(0.520;95%CI,0.395-0.643; < 0.05)。发热性尿路感染患儿中,贫血和入院时 NGAL 升高(>150ng/ml)是肾瘢痕的独立危险因素。在无肾受累的发热性 UTI 患儿、无瘢痕的 APN 患儿和有瘢痕的 APN 患儿中,随着贫血的出现,NGAL 水平逐渐升高。
发热性尿路感染患儿中,血浆 NGAL 水平升高可能与贫血和肾瘢痕有关。